 |
BioWorld-Insight-2002-08-19
Stock Winners and Losers For The Week
Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: July 2002
No Abstract
SEC, Accounting Boards To Put Squeeze On Reporting Practices
In the scandal-ridden business world - where allegations of accounting manipulations and insider trading have been flying like chopped food out of an untopped Martha Stewart food processor - biotechnology, like every other sector, has been spattered. (BioWorld Financial Watch)